Frequently Asked Questions

Get answers to common questions about Tesamorelin.

Many patients notice metabolic changes and reduced visceral fat within 8 to 12 weeks; optimal contouring often requires a full treatment course plus lifestyle measures. Individual response varies, and our clinicians review progress and adjust dosing accordingly.

Side effects are generally mild, including injection-site discomfort, transient swelling, or mild joint pain. Serious reactions are rare, and we screen for contraindications beforehand. Report any unusual symptoms promptly so our team can evaluate and manage them.

Candidates with stubborn visceral fat, unfavorable lipid profiles, and no contraindicating conditions may benefit. We perform medical evaluations, labs, and consultation to determine suitability and personalize dosing to align with body composition and cardiovascular health goals.

Treatment duration varies, commonly 3 to 6 months for measurable reductions, with some patients continuing longer under supervision. Our team tracks outcomes and recommends continuation, tapering, or alternative strategies based on individual response and safety monitoring.

Potential interactions and contraindications exist, especially with active cancer, pituitary disorders, or poorly controlled diabetes. Bring a full medication and medical history; we review labs and coordinate care with your providers to ensure safety before starting therapy.

Tesamorelin is given as a daily subcutaneous injection, typically self-administered after training. Clinic visits for monitoring, lab checks, and dose adjustments are scheduled regularly to ensure efficacy, safety, and adherence to the treatment plan.

fbq('track', 'Schedule')